BRTX logo

BioRestorative Therapies (BRTX) Net Income

Annual Net Income

-$10.42 M
+$2.80 M+21.21%

December 1, 2023


Summary


Performance

BRTX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBRTXprofitabilitymetrics:

Quarterly Net Income

-$1.09 M
+$2.94 M+72.91%

September 1, 2024


Summary


Performance

BRTX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBRTXprofitabilitymetrics:

TTM Net Income

-$9.65 M
-$5.86 M-154.71%

September 1, 2024


Summary


Performance

BRTX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBRTXprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BRTX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.2%-122.9%-34.2%
3 y3 years+7.6%+94.7%+78.2%
5 y5 years+16.8%+94.7%+78.2%

BRTX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+76.5%-122.9%+94.7%-154.7%+78.2%
5 y5-yearat high+76.5%-122.9%+94.7%-154.7%+78.2%
alltimeall time-360.2%+76.5%-122.9%+94.7%-2381.3%+78.2%

BioRestorative Therapies Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.09 M(-72.9%)
-$9.65 M(+154.7%)
Jun 2024
-
-$4.03 M(+81.2%)
-$3.79 M(-30.7%)
Mar 2024
-
-$2.22 M(-3.5%)
-$5.47 M(-47.5%)
Dec 2023
-$10.42 M(-21.2%)
-$2.30 M(-148.3%)
-$10.42 M(+44.9%)
Sep 2023
-
$4.77 M(-183.5%)
-$7.19 M(-56.7%)
Jun 2023
-
-$5.71 M(-20.4%)
-$16.61 M(+6.6%)
Mar 2023
-
-$7.17 M(-875.5%)
-$15.58 M(+17.8%)
Dec 2022
-$13.22 M(-70.2%)
$924.90 K(-119.9%)
-$13.22 M(-61.7%)
Sep 2022
-
-$4.66 M(-0.4%)
-$34.55 M(+1.4%)
Jun 2022
-
-$4.68 M(-2.9%)
-$34.08 M(+1.8%)
Mar 2022
-
-$4.82 M(-76.4%)
-$33.47 M(-24.5%)
Dec 2021
-$44.30 M(+293.0%)
-$20.40 M(+387.6%)
-$44.30 M(+49.4%)
Sep 2021
-
-$4.18 M(+3.0%)
-$29.66 M(+12.7%)
Jun 2021
-
-$4.06 M(-74.0%)
-$26.31 M(+35.8%)
Mar 2021
-
-$15.65 M(+171.7%)
-$19.38 M(+71.9%)
Dec 2020
-$11.27 M(-23.0%)
-$5.76 M(+588.9%)
-$11.27 M(+59.6%)
Sep 2020
-
-$836.30 K(-129.1%)
-$7.06 M(-37.4%)
Jun 2020
-
$2.88 M(-138.1%)
-$11.28 M(-38.4%)
Mar 2020
-
-$7.55 M(+387.0%)
-$18.32 M(+25.0%)
Dec 2019
-$14.65 M(+17.0%)
-$1.55 M(-69.3%)
-$14.65 M(-12.1%)
Sep 2019
-
-$5.06 M(+21.6%)
-$16.67 M(+14.7%)
Jun 2019
-
-$4.16 M(+7.1%)
-$14.54 M(+4.6%)
Mar 2019
-
-$3.88 M(+8.8%)
-$13.89 M(+11.0%)
Dec 2018
-$12.52 M(+32.5%)
-$3.57 M(+22.1%)
-$12.52 M(+15.8%)
Sep 2018
-
-$2.93 M(-16.8%)
-$10.81 M(+8.8%)
Jun 2018
-
-$3.51 M(+40.1%)
-$9.93 M(+8.4%)
Mar 2018
-
-$2.51 M(+34.9%)
-$9.17 M(-2.9%)
Dec 2017
-$9.44 M
-$1.86 M(-9.4%)
-$9.44 M(-2.0%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$2.05 M(-25.3%)
-$9.64 M(+2.3%)
Jun 2017
-
-$2.75 M(-1.4%)
-$9.42 M(+5.5%)
Mar 2017
-
-$2.79 M(+35.4%)
-$8.93 M(+3.5%)
Dec 2016
-$8.64 M(+9.0%)
-$2.06 M(+12.1%)
-$8.64 M(-11.0%)
Sep 2016
-
-$1.83 M(-18.8%)
-$9.70 M(+2.2%)
Jun 2016
-
-$2.26 M(-9.2%)
-$9.49 M(+9.7%)
Mar 2016
-
-$2.49 M(-20.3%)
-$8.65 M(+9.2%)
Dec 2015
-$7.92 M(+41.8%)
-$3.12 M(+92.1%)
-$7.92 M(+26.0%)
Sep 2015
-
-$1.62 M(+14.3%)
-$6.29 M(+9.1%)
Jun 2015
-
-$1.42 M(-19.3%)
-$5.77 M(+1.5%)
Mar 2015
-
-$1.76 M(+18.6%)
-$5.68 M(+1.6%)
Dec 2014
-$5.59 M(-2.8%)
-$1.48 M(+34.9%)
-$5.59 M(-2.6%)
Sep 2014
-
-$1.10 M(-17.4%)
-$5.73 M(-3.4%)
Jun 2014
-
-$1.33 M(-20.2%)
-$5.94 M(+1.4%)
Mar 2014
-
-$1.67 M(+2.4%)
-$5.85 M(+1.8%)
Dec 2013
-$5.75 M(-12.0%)
-$1.63 M(+25.2%)
-$5.75 M(-4.8%)
Sep 2013
-
-$1.30 M(+4.1%)
-$6.04 M(-2.8%)
Jun 2013
-
-$1.25 M(-20.1%)
-$6.21 M(-6.0%)
Mar 2013
-
-$1.57 M(-18.4%)
-$6.61 M(+1.1%)
Dec 2012
-$6.54 M(+60.5%)
-$1.92 M(+29.9%)
-$6.54 M(+21.9%)
Sep 2012
-
-$1.48 M(-10.3%)
-$5.36 M(+9.5%)
Jun 2012
-
-$1.65 M(+10.2%)
-$4.90 M(+9.9%)
Mar 2012
-
-$1.49 M(+101.2%)
-$4.46 M(+9.4%)
Dec 2011
-$4.07 M(+80.0%)
-$742.60 K(-26.7%)
-$4.07 M(-10.3%)
Sep 2011
-
-$1.01 M(-15.9%)
-$4.54 M(+15.9%)
Jun 2011
-
-$1.20 M(+8.2%)
-$3.92 M(+44.4%)
Mar 2011
-
-$1.11 M(-8.2%)
-$2.71 M(+69.5%)
Dec 2010
-$2.26 M
-$1.21 M(+211.8%)
-$1.60 M(+311.8%)
Sep 2010
-
-$388.80 K
-$388.80 K

FAQ

  • What is BioRestorative Therapies annual net profit?
  • What is the all time high annual net income for BioRestorative Therapies?
  • What is BioRestorative Therapies annual net income year-on-year change?
  • What is BioRestorative Therapies quarterly net profit?
  • What is the all time high quarterly net income for BioRestorative Therapies?
  • What is BioRestorative Therapies quarterly net income year-on-year change?
  • What is BioRestorative Therapies TTM net profit?
  • What is the all time high TTM net income for BioRestorative Therapies?
  • What is BioRestorative Therapies TTM net income year-on-year change?

What is BioRestorative Therapies annual net profit?

The current annual net income of BRTX is -$10.42 M

What is the all time high annual net income for BioRestorative Therapies?

BioRestorative Therapies all-time high annual net profit is -$2.26 M

What is BioRestorative Therapies annual net income year-on-year change?

Over the past year, BRTX annual net profit has changed by +$2.80 M (+21.21%)

What is BioRestorative Therapies quarterly net profit?

The current quarterly net income of BRTX is -$1.09 M

What is the all time high quarterly net income for BioRestorative Therapies?

BioRestorative Therapies all-time high quarterly net profit is $4.77 M

What is BioRestorative Therapies quarterly net income year-on-year change?

Over the past year, BRTX quarterly net profit has changed by -$5.86 M (-122.89%)

What is BioRestorative Therapies TTM net profit?

The current TTM net income of BRTX is -$9.65 M

What is the all time high TTM net income for BioRestorative Therapies?

BioRestorative Therapies all-time high TTM net profit is -$388.80 K

What is BioRestorative Therapies TTM net income year-on-year change?

Over the past year, BRTX TTM net profit has changed by -$2.46 M (-34.20%)